NYU Grossman School of Medicine Program

The NYU Grossman School of Medicine offers a specialized program in Pediatric Hematology-Oncology through its Division of Pediatric Hematology-Oncology, which is located at the Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders. This program is dedicated to providing comprehensive, family-centered care for children, adolescents, and young adults afflicted with cancer and hematological diseases. The mission of the division includes utilizing state-of-the-art therapies that are both effective and personalized, ensuring a healing environment that prioritizes the physical, emotional, and spiritual well-being of patients and their families 1.

The division is not only a clinical care provider but also a hub for innovative research. Investigators engage in modern biological research to uncover the underlying causes of childhood cancers and blood disorders, translating scientific discoveries into novel treatments. The division is particularly known for spearheading clinical trials that are rooted in fundamental laboratory discoveries, thus pushing the envelope in pediatric oncology research 1.

Curriculum Overview

The curriculum for training in Pediatric Hematology-Oncology is intensely focused on both clinical and research experiences. The program offers a robust fellowship that spans three years, providing fellows with the necessary skills to excel in both clinical care and research in this specialized area. The training occurs at various high-profile sites, including Hassenfeld Children’s Hospital, as well as NYC Health + Hospitals/Bellevue and NYC Health + Hospitals/Woodhull, which offer diverse learning environments 2.

Fellowship and Training Opportunities

Training options include a three-year fellowship accredited by the Accreditation Council for Graduate Medical Education (ACGME) focused on Pediatric Hematology-Oncology. Additionally, a one-year clinical fellowship in pediatric neuro-oncology is available, comprising extensive research opportunities in recognized laboratories. There are also opportunities for medical students and residents to participate in electives that provide broad clinical experiences across pediatric hematology and oncology 2.

Research Focus

The research endeavors within the program are geared towards understanding the specific causes of various conditions like leukemia, lymphoma, brain tumors, and spinal cord tumors. The faculty lead clinical trials and conduct basic and translational research in environments such as the Perlmutter Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center. The division actively collaborates with numerous prestigious centers through platforms such as the Children’s Oncology Group and the Pediatric Blood and Marrow Transplant Consortium, facilitating a multidisciplinary approach to pediatric cancer care 3.

Unique Aspects of the Program

One of the program's distinctive features is its commitment to training the next generation of pediatric hematologists and oncologists in a scientifically rich environment. The mentorship offered includes personalized guidance through a structured curriculum aimed at fostering leadership in the field. The program not only emphasizes research but also provides hands-on clinical experience, ensuring that each trainee develops into a well-rounded physician capable of providing exceptional care 13.

Visa Support and Competitiveness

The program offers visa support, including the ability to sponsor J-1 and H-1B visas for international medical graduates. This aspect of the program ensures that it is welcoming and accessible to qualified applicants from around the globe, making it increasingly competitive. The program is known for being IMG-friendly, and it accepts both DO and MD candidates, striving to create a diverse training cohort 2.

Application Requirements

Applicants to the Pediatric Hematology-Oncology fellowship must meet specific criteria, including having completed a core pediatrics clerkship prior to application. Additional application considerations may include limits on the number of failed STEP exams, although exact specifics should be verified during the application process. This rigorous application standard reflects the program's commitment to excellence and competence in its entrants 2.

Collaboration and Interdisciplinary Approach

The collaborative environment within the division is bolstered by partnerships with other medical disciplines, facilitating a comprehensive approach to patient care and research initiatives. Professionals from various backgrounds work together to advance the understanding and treatment of pediatric cancers, ensuring a holistic approach to the challenges in this field 3.